Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IGM Biosciences, Inc. (IGMS)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | | | 100.0% | 100.0% | | | | |
| Cost of goods sold | | | 0.0% | 0.0% | | | | |
| Gross profit | | | 100.0% | 100.0% | | | | |
| Research and development | | | 19264.3% | 32865.8% | | | | |
| General and administrative | | | 21501.9% | 40220.5% | | | | |
| Depreciation | | | 142.9% | 159.0% | | | | |
| EBIT | | | -31858.5% | -56213.4% | | | | |
| Pre-tax income | | | -31444.5% | -56091.5% | | | | |
| Income taxes | | | 0.0% | 0.0% | | | | |
| Net income | | | -31444.5% | -56091.5% | | | | |
|